
Keywords: 4-HNA; 4-hydroxynonenoic acid; 4-HNE; 4-hydroxynonenal; ACE; angiotensin converting enzyme; ALDH2; aldehyde dehydrogenase 2; ALS; amyotrophic lateral sclerosis; AMPK; AMP-activated protein kinase; ANZCTR; Australian New Zealand Clinical Trials Registry; B